Recurrent Verrucous Carcinoma of the Larynx Completed Phase 1 Trials for Fluorouracil (DB00544)
Also known as: Laryngeal verrucous carcinoma recurrent / Recurrent Laryngeal Verrucous Carcinoma / Squamous Cell Carcinoma of the Larynx / Laryngeal squamous cell carcinoma / Primary squamous cell carcinoma of larynx (disorder) / Squamous cell carcinoma of larynx (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029506 (Recurrent Verrucous Carcinoma of the Larynx) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00023959 | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | Treatment |